Veriheal

FEBRUARY 21, 2023

Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies.

Access 98

Access Patients Chronic Pain Conditions 98

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 252

Clinical Trials Chronic Pain Cannabinoids Patients 252

SpeedWeed

JANUARY 25, 2019

Prescription painkiller addicts can now seek medical cannabis as a form of treatment in New Jersey. Phil Murphy (D) on Wednesday announced that opioid addiction will be added to the list of qualifying conditions that allows residents to obtain medical marijuana, reports NJ.com. 20, averaging nearly 7 deaths per day. Oscar Pascual.

Treatment 65

Treatment Marijuana Conditions Data 65

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 243

Chronic Pain Therapy Patients Topical 243

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Veriheal

NOVEMBER 21, 2023

Quemarr Moatamedi School: University of Montana Major/Program: Linguistics and Anthropology Innovation: Emulsion-Based Edibles: Harnessing Anti-Diabetic Cannabinoids in Diabetes Management. Quemarr’s transformative approach to diabetes treatment offers patients a less intrusive alternative to conventional insulin treatments.

Research and Development 106

Research and Development Consumption Education Data 106

Cannabis Law Report

SEPTEMBER 17, 2021

HARRISBURG — The public could soon know for the first time how many patients use medical marijuana to treat opioid use disorder in Pennsylvania, one of the few states to specifically endorse that treatment option. Cordeiro died of an overdose a few weeks later.

Treatment 52

Treatment Patients Data Policy 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

The Cannigma

JUNE 30, 2021

But in addition to the 18 states with legal adult-use (as well as medical), there are another 18 states that have fully functioning medical marijuana programs. In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments.

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

AUGUST 3, 2021

Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. Medxtractor Corp.

Research and Development 105

Research and Development Data Conditions Therapy 105

Canna Law Blog

DECEMBER 16, 2021

The “purpose or general idea of bill” provides a good summary: this legislation would “create psilocybin service centers to provide innovative treatment options for ailments such as PTSD, depression, alcohol dependency, anxiety, among others.” Expansive List of Qualifying Medical Conditions. Broad Justification.

Legislation 97

Legislation Treatment Therapy Conditions 97

Cannabis Law Report

MAY 10, 2022

First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. Medicinal cannabis as a last resort.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Peninsula Alternative Health

MARCH 1, 2018

In 2016, Maryland contracted with ASA’s Patient Focused Certification program to train the officials tasked with watching over the state’s emerging medical cannabis program. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data.

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

In 2016, Maryland contracted with ASA’s Patient Focused Certification program to train the officials tasked with watching over the state’s emerging medical cannabis program. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data.

Treatment 40

Treatment Education Advocacy Access 40

Cannabis Law Report

JUNE 19, 2022

Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

The Cannigma

MARCH 2, 2021

They argued that their findings suggest that doctors “outside of the VHA system who treat veteran patients may need to take the lead in conversations surrounding medical marijuana as a treatment option.”. While medical marijuana is a legal treatment option in 33 states and Washington D.C.,

Research and Development 143

Research and Development Treatment Chronic Pain Sleep 143

Cannabis Law Report

DECEMBER 26, 2021

In furtherance of its program, the Company filed US Provisional Patent Application No. “Entheon is proud to be making significant strides in its Entheon IQ™ program,” says Timothy Ko, Chief Executive Officer of Entheon. US Provisional Patent Filed. ” In Vivo Toxicity Assays Completed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 25, 2022

Medical marijuana is only legal for those who suffer from a qualifying medical condition. To become a registered patient with legal rights to purchase medical marijuana, a state-licensed physician must determine that you would indeed benefit from this treatment. The Benefits of Medical Marijuana. Bottom Line.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

The Cannigma

JUNE 15, 2021

The first clinical research done on CBD as a potential treatment for epilepsy was in 1980, but the information gleaned didn’t make its way to the public eye until decades later. In other cases, CBDA products — or a mixture of CBD and CBDA — may be preferable, if for instance treatments with high doses of CBD have been unsuccessful for you.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

SpeedWeed

SEPTEMBER 17, 2021

The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment. . Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. Consequently, the scientific community was astounded to discover that the ground-grown plant may offer relief from widespread medical conditions , including: AIDS. Amyotrophic lateral sclerosis (ALS). Chronic pain.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

The Cannigma

MARCH 14, 2023

Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Many of the early medical cannabis states had strict lists of conditions for which cannabis could be legally used. And the process of adding additional conditions was often lengthy, difficult and mired in paternalism.

Policy 96

Policy Research and Development Conditions Consumption 96

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

OCTOBER 29, 2021

Using data from the National Survey on Drug Use and Health (2005–2014), the present study examined the associations between lifetime classic psychedelic use and two types of cardiometabolic disease: heart disease and diabetes. The Abstract is as follows. diet, alcohol and tobacco consumption, and exercise) 11.

Research and Development 52

Research and Development Treatment Data Conditions 52

CannaMD

DECEMBER 8, 2020

In 2019, for example, FBI data shows 495,871 arrests made for violent crime – compared to the 500,395 individuals who were arrested for marijuana possession with no additional charges. Need Advice About Florida’s Medical Marijuana Program? MORE PEOPLE ARRESTED FOR MARIJUANA POSSESSION THAN ALL VIOLENT CRIMES. Get Started.

Marijuana 105

Marijuana Chronic Pain Treatment Legalization 105

MedicalMarijuana.ca

APRIL 3, 2019

This week, New Jersey became the latest state to name opioid dependence as a qualifying condition for medical cannabis use. As we combat this crisis, it is critical that we use data-driven, evidence-based strategies to support individuals suffering from addiction and help them get on the path to recovery.”.

Data 40

Data Programs Treatment Patients 40

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The popularity of medical cannabinoids (MCs) treatment is growing, as more countries enable MCs treatment for various indications in adults 1. Metrics details. Introduction. Search strategy.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

JUNE 12, 2021

The Parker Psychedelic Research Chair is being funded by Calgary businessman Jim Parker, who donated $3 million to the Hotchkiss Brain Institute to establish the program. She says the treatment did little but left her feeling numb and unable to heal. The treatments were carefully dosed and conducted under medical supervision.

Therapy 105

Therapy Treatment Medicine Sleep 105

Cannabis Law Report

AUGUST 27, 2021

The Rules also create a pathway for Alternative Treatment Centers (ATC) previously licensed under New Jersey’s medical cannabis law to expand their operations to include recreational cannabis. New applicants may apply for either a conditional license or an annual license. Annual license fees vary with the class of license.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Cannabis Law Report

NOVEMBER 3, 2021

Khiron in the United Kingdom The company is pursuing a consistent approach to improve patient access to medical cannabis and to develop the market for medical cannabis treatments in the UK. Both virtual and in-person appointments can be made via the website www.zereniaclinic.co.uk.

Therapy 52

Therapy Access Patients Treatment 52

PrestoDoctor

SEPTEMBER 6, 2023

Traditionally, prescription codeine has been prescribed for a variety of conditions, including post-operative pain, dental procedures, and chronic pain. Some patients report relief from chronic pain conditions, such as neuropathy, arthritis, and fibromyalgia, when using cannabis products.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105